Biocryst Pharmaceuticals buy Cantor Fitzgerald
Start price
30.06.26
/
50%
€8.79
Target price
30.06.27
€25.44
Performance (%)
9.67%
Price
07.07.26
€9.64
Summary
This prediction is currently active. With a performance of 9.67%, the BUY prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals is trending in the right direction. This prediction currently runs until 30.06.27. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biocryst Pharmaceuticals | 10.197% |
| iShares Core DAX® | 1,77 % |
| iShares Nasdaq 100 | -3,50 % |
| iShares Nikkei 225® | -4,94 % |
| iShares S&P 500 | 0,30 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (BCRX) had its price target raised by Cantor Fitzgerald from $27.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.72
15.10.25
15.10.25
€22.38
15.10.26
15.10.26
68.53%
07.07.26
07.07.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.44
29.04.25
29.04.25
€17.56
29.04.26
29.04.26
1.64%
30.04.26
30.04.26